Morris Arlene
SEC-identified person · CIK 1362520 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Director | filed 2024–2026 |
| Unum Therapeutics, Inc. UNUM | Director | filed 2019–2026 |
| Palatin Technologies INC PTN | Director | filed 2015–2025 |
| Viridian Therapeutics, Inc.\DE VRDN | Director | filed 2018–2025 |
| Viveve Medical, INC. plcsf | Director | filed 2016–2023 |
| Dimension Therapeutics, Inc. DMTX | Director | filed 2015–2017 |
| Biodel Inc BIODEL | Director | filed 2015–2016 |
| Medicinova INC MNOV | Director | filed 2006–2013 |
| Affymax INC AFFY | Director · President and CEO | filed 2006–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.